Effects of BYL-719 (alpelisib) on human breast cancer stem cells to overcome drug resistance in human breast cancer
IntroductionBreast cancer continues to be a major health concern and is currently the most commonly diagnosed cancer worldwide. Relapse, metastasis, and therapy resistance are major clinical issues that doctors need to address. We believe BYL-719, which is PI3 kinase p110а inhibitor, could also inhi...
שמור ב:
Main Authors: | , , , , |
---|---|
פורמט: | ספר |
יצא לאור: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
אינטרנט
Connect to this object online.3rd Floor Main Library
סימן המיקום: |
A1234.567 |
---|---|
עותק 1 | זמין |